Sequence Bio
This message encourages proactive engagement and networking for future opportunities by inviting individuals to introduce themselves, even if current openings do not match their profile. It highlights the dynamic nature of job openings and the importance of staying connected.
Headquarters
St. John's, Newfoundland And Labrador, Canada
Company Size
51-200 employees
Founded
2013
Sequence Bio is a data-driven biotechnology company based in Newfoundland and Labrador that builds discovery cohorts from founder-population multi‑omics, comprehensive real‑world patient records, and well‑characterized phenotypes. Their systems‑biology platform and computational analytics aim to uncover the “true signals” of disease—including low‑frequency, high‑impact variants—to improve target discovery and lower the high failure rate in drug R&D. Sequence Bio partners with pharma and biotech on custom genetic studies and powered cohorts across common and rare diseases to shorten development timelines and enable life‑changing medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sequence Bio.
Sequence Bio didn’t post a salary, so this is our estimate from similar listings.